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J Hypertens 34:290–297 Copyright  2016 Wolters Kluwer Health, Inc. All rightsObjectives: The positive association between adiposity
and hypertension is well recognized. However, not all
overweight individuals have elevated blood pressure (BP).
Moreover, different factors may be associated with high BP
in normal-weight versus overweight individuals. The aim of
the current study was to examine the influence of
adiposity on the relationship between SBP and underlying
haemodynamic mechanisms in young adults.
Method: Data from 2502 patients were available from the
Enigma study. Detailed demographic, biochemical, and
haemodynamic data were obtained in all individuals. Data
were analysed between lower and upper tertiles of BMI
and SBP, separately for each sex.
Results: In normal-weight individuals, cardiac output (CO)
was elevated in those with higher SBP, independently of
body size. Moreover, higher CO was associated with an
increased stroke volume in men (P<0.001), but an increased
heart rate in women (P¼0.002). In contrast, in overweight
individuals, peripheral vascular resistance (PVR) was elevated
in men with higher SBP (P¼0.02) and those with lower SBP
had the lowest PVR of all groups. In linear regression
analyses, there was a stronger association between SBP and
CO in normal-weight individuals, but a stronger association
between SBP and PVR in overweight individuals.
Conclusion: Different haemodynamic mechanisms are
associated with elevated SBP in young adults, depending
on body size and sex. These data suggest the need for
differential approaches to the identification and
management of young adults with elevated BP.
Keywords: adiposity, BMI, cardiac output, peripheral
vascular resistance, SBP
Abbreviations: AIx, augmentation index; aPWV, aortic
pulse wave velocity; BP, blood pressure; CO, cardiac
output; ISH, isolated systolic hypertension; LDL, low-density
lipoprotein; MAP, mean arterial pressure; PP, pulse
pressure; PVR, peripheral vascular resistance; SV, stroke
volume; TC, total cholesterol
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ypertension is a common condition and an import-
ant cause of morbidity andmortality worldwide [1].
Although hypertension is relatively rare in young Copyright © 2016 Wolters Kluwe
290 www.jhypertension.comadults, the prevalence of isolated systolic hypertension
(ISH), the most common form of hypertension in the
young [2–4], is increasing [5] and is associated with car-
diovascular events in later life [6]. The underlying causes are
probably because of multiple factors, with obesity,
increased salt intake, and lack of physical activity all likely
to play a significant role [7,8]. Indeed, the increased preva-
lence of ISH in the young observed in National Health and
Nutrition Examination Survey III is thought to be because of
obesity and smoking [5], both important risk factors for
cardiovascular disease in later life.
Most studies report a positive association between blood
pressure (BP) and obesity [9–11]. However, not all hyper-
tensive patients are obese and not all obese individuals are
hypertensive [8]. This suggests a variation in the effect of
weight gain and that there may be adaptive or protective
changes with regard to BP. It is also unclear as to whether
the underlying pathophysiology differs between normal-
weight and overweight hypertensives. Moreover, sex
disparities in the natural history of hypertension have been
examined [12–15], but the underlying haemodynamic
mechanisms remain unclear.
We wished to examine the pathophysiology of BP
elevation in young individuals, focusing on haemodynamic
mechanisms and their relationship with weight and sex. We
hypothesized that different haemodynamic mechanisms
are responsible for elevated SBP in normal-weight versus
overweight young adults and our aim was to test this
hypothesis in a large population of young adults from
the Enigma study.r Health, Inc. All rights reserved.
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Adiposity and SBPMETHODS
Participants were drawn from the Enigma study population,
which investigates the origins of hypertensionwith regard to
clinical, physiological, and genetic characteristics [4]. Com-
plete data were available in 2502 individuals, selected at
random from two university populations in the United King-
dom (Cambridge and Wales). All individuals were aged
between 18 and 40 years. Patients with secondary forms
of hypertension or overt cardiovascular disease were
excluded. Patients with diabetes mellitus, a serum choles-
terol of 6.5mmol/l, and/or renal diseasewere also excluded,
as were patients receiving any vasoactive medication. The
study was approved by the Local Research Ethics Commit-
tees, and all participants gave informed consent.
Protocol
All participants completed a detailed lifestyle and medical
history questionnaire and height, weight, and waist circum-
ference were assessed and BMI was calculated. After 15min
of seated rest, brachial BP and radial artery waveforms were
recorded. Following 20min of supine rest, brachial BP and
radial artery waveforms were reassessed, and pulse wave
velocity (PWV) and cardiac output (CO) were determined,
as described below.
Approximately 20ml of blood was drawn from the
antecubital fossa into plain tubes. The samples were cen-
trifuged at 48C (4000 rpm for 20min) and the serum sep-
arated and stored at 808C for subsequent analysis. Total
cholesterol (TC), triglycerides, low-density lipoproteins
(LDL), high-density lipoproteins (HDL) and glucose were
assessed by standard automated biochemistry on a 2400
clinical chemistry system (Advia; Siemens Healthcare Diag-
nostics Inc, Newark, Delaware, USA) in an accredited
laboratory. The LDL was calculated.
Haemodynamics
Brachial BP was recorded in the dominant arm using
appropriately sized cuffs and a validated oscillometric
technique (HEM-705CP; Omron Corporation, Tokyo, Ja-
pan). Readings were taken in duplicate, or triplicate if
readings differed by more than 5mmHg. Radial artery
waveforms were recorded with a high-fidelity microman-
ometer (SPC-301; Millar Instruments, Houston, Texas, USA)
from thewrist of the dominant arm, and pulse wave analysis
(SphygmoCor; AtCor Medical, West Ryde, New South
Wales, Australia) used to generate a corresponding central
(ascending aortic) waveform, as validated previously [16].
From this, central BP, augmentation index (AIx), augmen-
tation pressure (AP), mean arterial pressure (MAP), and
heart rate were calculated, as described previously [17].
Carotid–femoral (aortic) pulse wave velocity (aPWV) was
recorded using the same device, as described previously
[17]. In the subsequent analysis, augmentation pressure and
augmentation index were adjusted for age, height, and
heart rate, whereas aPWV was adjusted for age and MAP.
Cardiac output was assessed using a non-invasive, inert
gas rebreathing technique, which has previously been vali-
dated against thermodilution and direct Fick methods for
measurement of pulmonary blood flow and, thus, cardiac
output [18–22]. Briefly, while resting, participants were Copyright © 2016 Wolters Kluwer
Journal of Hypertensioninstructed to continuously rebreathe a gas mixture (1%
SF6, 5% N20, and 94% O2) over 20 s, at a rate of
20breaths/min. Expired gases were sampled continuously
and analysed by an infrared photoacoustic gas analyser
(Innocor; Innovision A/S, Odense, Denmark), for the deter-
mination of CO and stroke volume (SV). Peripheral vascular
resistance (PVR) was calculated from the formula: PVR
(dynes/s/cm5)¼MAP (mmHg) 80/CO (l/min). Trained
investigators made all measurements. The within and
between-observer measurement reproducibility values for
the arterial stiffness and cardiac output measurements were
in agreement with our previously published data [4,17].
Statistical analysis
Data were analysed using Statistical Package for Social
Sciences software (version 20.0; IBM, Armonk, New York,
USA). The influence of BMI on SBP and the underlying
haemodynamic mechanisms was examined using two
approaches. Firstly, within each sex, participants were
stratified into tertiles of SBP and BMI, with comparisons
made between the upper and lower tertiles (i.e. the
extremes), as an alternative to arbitrary thresholds, which
might not be applicable to young adults. Independent
samples t-tests and one-way analysis of variance were used
to determine significant differences between the groups.
Posthoc analyses were conducted using the Bonferroni
method and Pearson x2 method for categorical data. The
independent samples, Kruskal–Wallis test was conducted
for non-normally distributed data. Separately, linear
regression models were constructed, treating all data as
continuous variables, including terms for the interaction
between BMI and haemodynamic factors (CO or PVR). All
data are presented as means SD unless otherwise stated.
The null hypothesis was rejected at P< 0.05.
RESULTS
The demographics and basic haemodynamic characteristics
of the study population are presented by sex in Table 1.
Overall, CO was higher in men, and ISH was the most
common form of hypertension. In contrast, PVR was higher
in women and systolic diastolic hypertension was the most
common form of hypertension.
Biochemical characteristics
The demographic and biochemical characteristics are
shown in Tables 2 and 3, for men and women, respectively.
Applying the WHO criteria, participants in the lower BMI
were categorized as ‘normal weight’ whereas those in the
highest tertile were categorized as ‘overweight’. In both
men and women, being overweight was associated with an
adverse biochemical profile (higher TC, LDL triglycerides,
glucose, and significantly lower high-density lipoproteins)
compared with normal-weight individuals. This adverse
profile was more pronounced in those participants who
were overweight and had higher SBP.
Haemodynamic characteristics
The haemodynamic characteristics are shown in Tables 4
and 5, for men andwomen, respectively. Those in the lower Health, Inc. All rights reserved.
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TABLE 1. Demographic and haemodynamic characteristics of the whole study population, by sex
Parameter Men n¼1255 Women n¼1247 Overall P
Age (years) 236 236 0.04
Height (m) 1.790.07 1.660.07 <0.001
Weight (kg) 7814 6412 <0.001
Body mass index (kg/m2) 24.33.9 23.24.1 <0.001
Systolic blood pressure (mmHg) 12814 11414 <0.001
Diastolic blood pressure (mmHg) 7711 7411 <0.001
Cardiac output (l/min) 8.42.1 6.51.5 <0.001
Heart rate (beats/min) 7212 7512 <0.001
Peripheral vascular resistance (dynes/s/cm5) 881243 1066281 <0.001
Systolic diastolic hypertension (%) 8.8 4.3 <0.001
Isolated systolic hypertension (%) 12.0 1.4 <0.001
Isolated diastolic hypertension (%) 3.8 4.2 0.68
Data are means SD.
Pearson x2.
Middlemiss et al.tertile of SBP were classified as having either optimal or
normal BP, according to the recent European Society of
Hypertension guidelines [23]. However, women in the
upper tertile of SBP had either normal or high-normal
BP, whereas men portrayed a predominantly ISH
phenotype.Normal-weight individuals
In normal-weight individuals, COwas elevated in both men
and women with higher SBP versus those with lower SBP.
These differences remained after adjusting for differences
in body size between the groups (Fig. 1). The higher CO in
men was driven by a higher SV, which remained after
adjusting for body size. In contrast, the higher CO in
women was driven by a higher heart rate. There were
no differences in other haemodynamic mechanisms
between SBP groups in men. However, PVR adjusted for
body size and augmentation pressure were elevated in
women with higher SBP versus those with lower SBP.
Higher brachial SBP was associated with a higher central
SBP in both men and women and pulse pressure (PP)
amplification did not differ between SBP groups in Copyright © 2016 Wolters Kluwe
TABLE 2. Demographic and biochemical characteristics in men, accord
Normal weight
Characteristic Lower SBP n¼210 Higher SBP n
Age (years) 225 225y
Height (m) 1.790.07 1.810.07
Weight (kg) 657 687y
BMI (kg/m2) 20.31.4 20.81.1y
Family history of hypertension (%) 23 38
Regular exercise (yes %) 81 86
Alcohol (units/week) 1111 1312
Current smoker (%) 10 15
Waist circumference (cm) 745 764y
TC (mmol/l) 3.740.8 4.051.3y
LDL (mmol/l) 2.010.68 2.231.2y
HDL (mmol/l) 1.370.32 1.410.37
Triglycerides (mmol/l) 0.890.56 1.00.52
Glucose (mmol/l) 4.670.79 4.831.0
Data are means SD. #Refers to non-normally distributed data. BMI, body mass index; HDL, hig
P<0.05 versus normal-weight, lower SBP.
yP<0.05 normal-weight, higher SBP versus overweight, higher SBP.
zP<0.05 overweight, lower SBP versus overweight higher SBP.
292 www.jhypertension.comeither men or women (Figure S1, Data Supplement,
http://links.lww.com/HJH/A559).
Overweight individuals
In overweight individuals, CO was slightly higher in men
and women with higher SBP versus those with lower SBP,
but this trend was not significant, and adjusting for body
size abolished any meaningful differences between SBP
groups. However, in men, PVR was markedly higher in
those with higher SBP, although this was not the case in
women. In both men and women, PVR adjusted for body
size was lowest of all in those with lower SBP. In women,
higher SBP was associated with significantly higher aug-
mentation pressure, AIx, and aPWV.
Influence of BMI on the relationship between
SBP, cardiac output, and peripheral vascular
resistance
To examine further the influence of adiposity on the
relationship between SBP, CO, and PVR, linear regression
analyses were performed, using the entire cohort, treat-
ing the data as continuous variables. Overall, there was ar Health, Inc. All rights reserved.
ing to level of SBP and BMI
Overweight
¼68 Lower SBP n¼88 Higher SBP n¼212 Overall P
258 267 <0.001#
1.780.07 1.790.06 0.07
9012 9212 <0.001
28.32.8 28.82.96 <0.001
36 47 <0.001#
78 80 0.6#
1313 1413 0.04#
14 16 0.08#
939 928 <0.001
4.200.9 4.631.10,z <0.001
2.40.8 2.651.02 <0.001
y 1.210.2 1.210.29 <0.001
y 1.310.8 1.751.33,z <0.001
4.961.26 5.020.76 0.02
h-density lipoproteins; LDL, low-density lipoproteins; TC, total cholesterol.
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TABLE 3. Demographics and biochemical characteristics in women, according to level of SBP and BMI
Normal weight Overweight
Characteristic Lower SBP n¼197 Higher SBP n¼81 Lower SBP n¼91 Higher SBP n¼189 Overall P
Age (years) 224 246 226 257,z <0.001#
Height (m) 1.650.06 1.660.07 1.650.07 1.650.07 0.5
Weight (kg) 535 565y 7311 7713,z <0.001
BMI (kg/m2) 19.41.2 20.10.7y 26.733.6 28.104.2,z <0.001
Family history of hypertension (%) 24 35 29 51,z <0.001#
Regular exercise (yes) 81 90 78 76 0.06#
Alcohol (units/week) 55 79 86 87 <0.001#
Current smoker (%) 5 10 15 13 0.02#
Waist circumference (cm) 68.17.2 69.05.2y 81.59.2 84.310.5 <0.001
TC (mmol/l) 4.150.9 4.370.8 4.250.82 4.540.95 <0.001
LDL (mmol/l) 2.300.8 2.340.7,y 2.360.76 2.580.82 0.009
HDL (mmol/l) 1.560.4 1.670.4y 1.460.3 1.460.4 <0.001
Triglycerides (mmol/l) 0.780.4 0.890.4y 1.050.7 1.200.8 <0.001
Glucose (mmol/l) 4.410.8 4.640.88 4.720.7 4.670.6 0.002
ata are means SD. #Represents independent samples Kruskal–Wallis test for non-normally distributed data. BMI, body mass index; HDL, high-density lipoproteins; LDL, low-density
oproteins; TC, total cholesterol.
<0.05 versus normal-weight, lower SBP.
<0.05 normal-weight, higher SBP versus overweight, higher SBP.
<0.05 overweight, lower SBP versus overweight, higher SBP.
Adiposity and SBPD
lip
P
yP
zPsignificant, positive association between SBP and cardiac
output in both men (r¼ 0.27, P< 0.001) and women
(r¼ 0.25, P< 0.001). However, although similar associ-
ations were evident in normal-weight men (r¼ 0.31,
P< 0.001) and women (r¼ 0.27, P< 0.001), the associ-
ations were much weaker in overweight men (r¼ 0.10,
P< 0.05) and women (r¼ 0.12, P< 0.05). Indexing
the cardiac output to body size did not alter the associ-
ations, as depicted graphically, using tertile analyses, in
Figure 1.
There was a small, though significant association
between SBP and PVR in women (r¼ 0.16, P< 0.001) over-
all, but not in men (r¼ 0.04, P¼ 0.2). However, there were
stronger, positive associations between SBP and PVR in
overweight men (r¼ 0.21, P< 0.001) and women (r¼ 0.28, Copyright © 2016 Wolters Kluwer
TABLE 4. Haemodynamic characteristics in men
Normal weight
Characteristic Lower SBP n¼210 Higher SBP n¼6
Brachial SBP (mmHg) 1137 1428,y
Brachial DBP (mmHg) 706 8210,y
Central SBP (mmHg) 966 10910,y
PP amplification (ratio) 1.640.13 1.680.13y
MAP (mmHg) 836 9910,y
Heart rate (beats/min) 7212 7412
Cardiac output (l/min) 7.52.1 9.32.7
Cardiac index (l/min per m2) 4.11.0 4.91.3,y
Stroke volume (ml) 9932 11741
Stroke volume index (ml/m2) 5416 6221,y
PVR (dynes/s/cm5) 904255 908343
PVRI (dynes/s/cm5/m2) 506163 487197
Adjusted AP (mmHg) 0.63.9 0.63.8
Adjusted AIx (%) 1.410.9 1.910.6
Adjusted a PWV (m/s) 5.930.86 5.950.81
Data are means SD. Aortic pulse wave velocity adjusted for age and mean arterial pressure; a
AP, augmentation pressure; AIx, augmentation index; MAP, mean arterial pressure; PP, pulse pr
P<0.05 versus normal-weight, lower SBP.
yP<0.05 normal-weight, higher SBP versus overweight, higher SBP.
zP<0.05 overweight, lower SBP versus overweight, higher SBP.
Journal of HypertensionP< 0.001), but not in normal-weight individuals (men:
r¼ 0.02, P¼ 0.6; women: r¼ 0.1, P¼ 0.06). Again, adjusting
for body size did not alter the associations (Fig. 2).
A series of stepwise multivariable regression models
were then constructed in the same individuals to investigate
whether the associations described above were independ-
ent of confounding factors. Both CO and PVR were inde-
pendently associated with SBP, together with age, sex, and
BMI (R2¼ 0.56, P< 0.001, Supplementary Table 1, http://
links.lww.com/HJH/A559). In addition, there were signifi-
cant interactions between BMI and CO (model 2, http://
links.lww.com/HJH/A559), PVR (model 3, http://links.
lww.com/HJH/A559), and both CO and PVR (model 4,
http://links.lww.com/HJH/A559), with the final model
explaining 67% of the variance in SBP. Health, Inc. All rights reserved.
Overweight
6 Lower SBP n¼87 Higher SBP n¼199 Overall P
1155 14611,z <0.001
758 8811,z <0.001
1007 11612,z <0.001
1.560.14 1.620.16z <0.001
877 10510,z <0.001
7010 7513z 0.002
8.5.2.2 8.92.0 <0.001
4.01.0 4.20.9 <0.001
11629 11530 <0.001
5513 5514 0.006
799222 926245z 0.02
385117 445130 <0.001
0.23.8 0.83.9 0.09
0.910.7 1.510.9 0.16
6.110.82 6.130.97 0.1
ugmentation pressure and augmentation index adjusted for age, heart rate, and height.
essure; PVR, peripheral vascular resistance; PVRI, Peripheral vascular resistance index.
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TABLE 5. Haemodynamic characteristics in women
Normal weight Overweight
Characteristic Lower SBP n¼197 Higher SBP n¼79 Lower SBP n¼91 Higher SBP n¼173 Overall P
Brachial SBP (mmHg) 1006 1269,y 1024 13012,z <0.001
Brachial DBP (mmHg) 676 829 696 8411,z <0.001
Central SBP (mmHg) 877 10512y 917 10914,z <0.001
PP amplification (ratio) 1.590.17 1.580.21 1.580.18 1.540.2 0.03
MAP (mmHg) 776 979 805 10011,z <0.001
Heart rate (beats/min) 7212 7813 7311 7612 <0.002
Cardiac output (l/min) 5.81.4 6.61.6 6.51.5 7.01.7 <0.001
Cardiac index (l/min per m2) 3.60.9 4.10.99 3.60.7 3.80.9 <0.001
Stroke volume (ml) 8021 7923y 8521 8823 <0.003
Stroke volume index (ml/m2) 5112 4913 4711 4812 <0.04
PVR (dynes/s/cm5) 1106280 1176390 1018263 1117323 0.17
PVRI (dynes/s/cm5/m2) 710198 737261y 573172 619204 <0.001
Adjusted AP (mmHg) 1.63.6 3.03.6 1.73.6 3.63.6,z <0.001
Adjusted AIx (%) 5.711.7 8.811.5 6.111.4 10.211.6,z 0.003
Adjusted PWV (m/s) 5.490.84 5.710.78 5.640.76 5.790.90 0.04
Data are means SD. Aortic pulse wave velocity adjusted for age and mean arterial pressure; augmentation pressure and augmentation index adjusted for age, heart rate, and height.
AP, augmentation pressure; AIx, augmentation index; MAP, mean arterial pressure; PP, pulse pressure; PVR, peripheral vascular resistance; PVRI, Peripheral vascular resistance index.
P<0.05 versus normal-weight, lower SBP.
yP<0.05 normal-weight, higher SBP versus overweight, higher SBP.
zP<0.05 overweight, lower SBP versus overweight, higher SBP.
Middlemiss et al.DISCUSSION
We have investigated the relationship between elevated
BMI and SBP with regard to haemodynamic and bio-
chemical factors. As such, the current study provides a
comprehensive examination of factors potentially under-
lying the association between adiposity and SBP in young
adults. Our key findings were that increased CO was the
predominant haemodynamic mechanism associated with
higher SBP in normal-weight individuals. However, in
overweight individuals, increased PVR, rather than CO,
was associatedwith higher SBP, and overweight individuals
with lower SBP had the lowest PVR of all groups. These data
suggest that the mechanisms underlying increased SBP in
young adults depend on body size, which may hold import-
ant implications for the treatment of high SBP in the young.80
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294 www.jhypertension.comPrevious haemodynamic studies in young adults have
focused on individuals with either borderline [24] or sus-
tained hypertension [25], and highlighted that an increased
CO appears to be the key haemodynamic determinant of
elevated BP in both normal-weight and obese individuals,
albeit with different underlying mechanisms. In normal-
weight participants, increased COwas thought to be associ-
ated with a hyperadrenergic state [26] whereas in obese
individuals, adrenergic activity was thought to be normal
but intravascular volume increased [27]. Although these
earlier studies provided important insights into obesity-
associated hypertension, the studies were relatively small
and did not permit sex-specific analyses. Moreover, the
average age of the study populations was 30 years and
whether these patterns are evident in younger adults isr Health, Inc. All rights reserved.
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Adiposity and SBPunclear. Furthermore, CO was assessed using invasive
methods, which may not be representative of the ‘usual’
resting state andmay have elicited different stress responses
between the different BP groups.
In the current study, we chose to examine haemody-
namic characteristics across tertiles of SBP and in linear
regression analyses, because these approaches did not rely
on any arbitrary BP thresholds, which may not apply
equally to men and women or simply to young adults
per se. In addition, we examined CO using an inert gas
rebreathing technique, which has been extensively vali-
dated to provide an accurate, non-invasive measurement of
CO [18–22], without inducing stress responses typically
seen with invasive measurements. In keeping with the
studies mentioned above [24–27], we observed that elev-
ated CO appeared to be the primary haemodynamic abnor-
mality associated with elevated SBP in normal-weight
individuals. However, we also noted that the raised CO
was predominantly because of a high SV in men but high
heart rate in women. To our knowledge, these are the first
data describing such an effect of sex on the components of
CO in young adults. As such, they confirm and extend our
previous observations in young adults with ISH [4], which is
almost exclusively confined to young men, largely because
of the 140mmHg threshold used to define the condition.
Moreover, the current data highlight that different strategies
may be needed to lower CO in men and women, if, indeed,
this were considered a useful approach to lowering BP in
young adults. Higher brachial SBP was also associated with
a higher central SBP in both men and women. However, PP
amplification did not differ between SBP groups in normal-
weight individuals. Taken together, these observations
argue strongly against any contention [28,29] that elevated
SBP in young adults simply arises from exaggerated ampli-
fication of ‘normal’ central SBP.
We also observed that although COwas slightly higher in
overweight, compared with normal-weight individuals,
adjusting for body size abolished any differences between
groups. Indeed, it is well recognized that CO, together with
total blood volume, increases with body size [24,26,30,31].
Therefore, although elevated CO might be characteristic of
overweight individuals with high SBP, this is likely to be
because of secondary, passive effects of increased body
size, rather than being a primary pathological mechanism.
In contrast, elevated PVR appeared to be the primary
haemodynamic abnormality associated with high SBP in
overweight individuals. This was particularly apparent in
linear regression analyses, where the association between
PVR and SBP was significant in overweight, but not normal-
weight individuals. Moreover, using the entire study
sample, there was an independent, negative interaction
between BMI and CO in association with SBP, but an
independent, positive interaction between PVR and BMI
indicating a stronger association between PVR and SBPwith
increasing adiposity. The interaction between BMI, CO, and
PVR was strongest of all, with the model containing this
term explaining the largest proportion of the variance in
SBP, suggesting that adiposity has a significant influence on
the interaction between CO and PVR in determining the
level of SBP within an individual. Interestingly, PVR was
lowest of all in overweight individuals with low SBP, Copyright © 2016 Wolters Kluwer
Journal of Hypertensionespecially after adjusting for body size. This observation
highlights that an important adaptive mechanism may be
present in at least some overweight individuals, which
allows them to maintain lower levels of SBP despite their
larger size. Such a mechanism may be related to structural
or functional differences in the peripheral vasculature,
either as a result of genetic predisposition and/or mainten-
ance of a healthier obese phenotype [32] although clearly
these hypotheses require testing in longitudinal studies.
Nevertheless, the current data suggest that a greater under-
standing of the factors underlying adaptations in PVR is
likely to provide important insights into the pathophysiol-
ogy of hypertension in young adults.
Obesity and hypertension are frequently associated with
metabolic abnormalities [33]. Previous data in young adults
from the Tecumseh study [34] highlighted an adverse meta-
bolic profile in individuals with borderline hypertension
compared with those with normal BP. However, individ-
uals were not stratified by BMI and those with borderline
hypertension were more likely to be overweight (30%)
than those with normal BP (13%). In the current study, we
observed that a combination of high SBP and high BMI was
associated with a worse biochemical profile, in terms of TC,
and triglyceride levels, than with either factor studied in
isolation. This was not altogether surprising, since risk
factors tend to cluster, even in low-risk individuals [35].
However, the association with an adverse biochemical
profile appears to depend more heavily on BMI rather than
SBP, because stratification based on SBP alone revealed
only incremental differences in biochemical profile
between groups, whereas stratifying by BMI had a marked
effect on biochemical profile, in both men and women.
Interestingly, higher alcohol consumption was evident
in men and women with high SBP and there was a higher
prevalence of smoking in overweight men with high SBP
indicating that lifestyle factors may impact on the develop-
ment of raised BP in young adults. Indeed, our data are in
agreement with recent findings from National Health and
Nutrition Examination Survey [5] demonstrating an
increased prevalence of smoking in young adults with ISH.
More recently, the concept of early vascular ageing has
received attention, particularly with regard to obesity,
because early vascular changes are hypothesized to
precede clinical manifestations of arterial hypertension in
obesity, as reviewed by Jordan et al. [36]. In the current
study, central SBP was highest in overweight individuals
with increased brachial SBP, and PP amplification tended to
be lowest in these individuals, suggestive of a higher central
SBP for a given level of a brachial BP. In contrast, however,
aPWV, a key biomarker of the early vascular ageing syn-
drome [37], was only elevated in overweight women with
high SBP, after adjustment for the level of BP. As high-
lighted recently [36], the literature concerning the associ-
ation between adiposity and aortic stiffness is yet to reach a
consensus and further studies, with appropriate controls for
confounding factors, are required.
Limitations
There are a number of limitations of our study. Cross-
sectional analyses do not permit causality to be examined
and further longitudinal studies of weight gain and loss Health, Inc. All rights reserved.
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this analysis. In addition, our stratification was based, in
part, on BMI, which is only a surrogate measure of body
fatness and does not provide an accurate measure of body
composition, particularly in highly muscular individuals
[38]. Nevertheless, BMI is the most frequently used diag-
nostic tool in the classification of overweight and obesity.
Lastly, we cannot exclude the possibility of an increased
white-coat effect amongst the overweight individuals with
high SBP, as reported previously [39,40], although every
effort was made to ensure a quiet environment and stand-
ardized measurement conditions for all study participants.
Ambulatory BP monitoring would be desirable in future
studies.
Clinical implications
Sustained essential hypertension is irreversible and remains
a major risk factor for cardiovascular events. Moreover,
recent evidence from younger and middle-aged adults
demonstrates that ISH is associated with increased long-
term risk for cardiovascular mortality compared with those
with optimal or normal BP [6]. Therefore, understanding the
mechanisms associated with early increases in BP is an
important aim of strategies designed to identify those at risk
of becoming hypertensive and/or preventing the longer-
term development of the condition. We have demonstrated
that the mechanisms underlying elevated SBP in young
adults differs according to adiposity, with CO being the key
abnormality in normal-weight individuals, and PVR being
key in overweight individuals. This has important implica-
tions for the management of high SBP in young adults
because existing therapies, which reduce CO, such as
b-blockers, may be more useful in normal-weight young
patients, whereas peripheral vasodilators may be more
appropriate in overweight or obese patients, although
clearly, further studies are required. Nevertheless, if target-
ing therapies toward the underlying abnormality is thought
to be a useful strategy in retarding the development of
hypertension, then choice of therapy may be dictated by
body size.
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